Semaglutide was linked to a 44% lower risk of worsening depression, 38% reduced chance of worsening anxiety, and 47% decreased likelihood of worsening substance use disorder
Peptide Dosing Protocols editorial team Per-protocol reconstitution math and dosing references for BPC-157, semaglutide, tirzepatide, retatrutide, TB-500, and CJC-1295/Ipamorelin
Seek emergency medical attention (call 999 or go to A&E) if you experience: Chest pain or difficulty breathing Severe allergic reaction (anaphylaxis), including swelling of the face, lips, or throat Loss of consciousness or collapse Sudden, severe abdominal pain For patients who have sourced retatrutide outside of a clinical trial which is strongly discouraged it is particularly important to inform your GP or a pharmacist, as there is no licensed prescribing information to guide safe use, and the risk of dosing errors or contaminated products is significant
It alters the body's normal digestive process by decreasing the amount of calories and nutrients the body can absorb
Retrieved from (n.d.)